Is cbdMD, Inc. technically bullish or bearish?
2025-09-20 19:56:50As of 2 September 2025, the technical trend for cbdMD, Inc. has changed from bearish to mildly bearish. The current stance is mildly bearish, driven by conflicting indicators: the MACD is mildly bullish on both weekly and monthly time frames, while Bollinger Bands are bearish on the monthly and mildly bearish on the weekly. The daily moving averages indicate a bearish trend. The KST shows a mildly bullish signal on the weekly but bearish on the monthly, and the OBV is mildly bullish on the weekly with no trend on the monthly. In terms of performance, cbdMD, Inc. has seen a 1-week return of 2.95% compared to the S&P 500's 1.05%, and a 1-month return of 5.82% against the S&P 500's 2.33%. However, year-to-date, the stock is down 76.01%, significantly underperforming the S&P 500, which is up 12.22%....
Read MoreIs cbdMD, Inc. overvalued or undervalued?
2025-09-20 18:30:37As of 9 February 2021, cbdMD, Inc. moved from fair to risky, indicating a deterioration in its valuation outlook. The company appears to be overvalued, particularly given its negative financial metrics. The Price to Book Value stands at 8.51, while the EV to EBITDA ratio is 7.49, suggesting that the market is pricing the company at a premium despite its loss-making status. Additionally, the ROE is alarmingly low at -119.47%, highlighting significant inefficiencies in generating returns for shareholders. In comparison to its peers, cbdMD, Inc. has a P/E ratio of -3.7225, which is less favorable than Mannatech, Inc. at -6.5265 and Flora Growth Corp. at -1.0973, both of which also face challenging valuations. The company's stock has significantly underperformed against the S&P 500, with a year-to-date return of -76.01% compared to the index's 12.22%, reinforcing the notion that it is overvalued in the current...
Read More





